All News about Alimera Sciences Inc
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://mms.businesswire.com/media/20240628907451/en/1919461/22/Latest_KSF_M%26A.jpg)
![](/next-assets/images/schema-image-default.png)
A Preview Of Alimera Sciences's Earnings
March 06, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Alimera Sciences
August 14, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/25/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop)
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
June 25, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](/next-assets/images/schema-image-default.png)
Preview: Alimera Sciences's Earnings
August 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Alimera Sciences
June 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/24/Wall-Street-US-stocks.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/12/mlgo1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/10/mergers-acquisitions.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/24/ANIP.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](/next-assets/images/schema-image-default.png)
4 Analysts Have This to Say About Alimera Sciences
May 19, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/12/number-g8f03ffd27_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/19/image23.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/19/dxc_technology_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/18/monro_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.